If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.95
Bid: 28.90
Ask: 29.10
Change: 0.50 (1.76%)
Spread: 0.20 (0.692%)
Open: 29.00
High: 30.25
Low: 28.40
Prev. Close: 28.45
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE plc: Development of IQGeVCSEL 150™ technology

2 Nov 2020 07:00

RNS Number : 8321D
IQE PLC
02 November 2020
 

IQE plc

Reach

 

Cardiff, UK

2 November 2020

 

 

 

IQE announces the successful development of IQGeVCSEL 150™ technology

 

 

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading manufacturer of advanced semiconductor wafer products for the global semiconductor industry, is pleased to announce the successful development of its IQGeVCSEL 150™ technology for 6" Vertical Cavity Surface Emitting Lasers (VCSELs) on Germanium (Ge), a critical step in the pathway to 200 mm and 300 mm VCSEL technology.

VCSELs are a key component in telecom and 3D sensing systems. Applications include high speed datacentre infrastructure; facial recognition, proximity sensing and LiDAR time-of-flight sensors on mobile handsets; in-cabin and environmental sensing for autonomous drive vehicles; and 3D image recognition. As demand for VCSELs grows and technical requirements become more stringent, there is the need to scale to larger wafer diameters and demonstrate a path for integration with leading edge CMOS technology. IQGeVCSEL 150™ is a key development milestone in addressing this. Germanium substrates are readily available in diameters up to 200 mm and provide a clear route for VCSEL growth on Si substrates (through the use of IQE's world-leading Ge on silicon templates) up to 300 mm.

Using this unique, patent pending technology, IQE has demonstrated device performance parity between identical VCSEL structures grown on Ge and conventional Gallium Arsenide (GaAs). While the conventional growth of VCSELs on 200 mm GaAs substrates is currently virtually impossible, the use of Ge removes this limitation. This is because Ge substrates allow for optimal strain management, resulting in a VCSEL wafer that is ~10x flatter compared to VCSEL on GaAs. This not only simplifies the subsequent wafer fabrication process but results in a wafer that is up to ~3x more uniform. The improved wafer flatness provides additional design flexibility for thicker device architectures required to access longer wavelength VCSELs. Finally, the Ge substrates are available with zero defect density, resulting in higher quality VCSEL epi material compared with GaAs.

Dr Rodney Pelzel, Chief Technology Officer of IQE, commented:

"I am delighted to announce the successful development of IQGeVCSEL 150™ technology. Demonstrating device parity with GaAs but with a more uniform VCSEL wafer and improved flatness is a highly significant milestone, and we have begun sampling with partners and customers. In addition, this provides clear line of sight to growth on larger diameter wafers as well as VCSEL growth on silicon at 200 mm and 300 mm wafer sizes."

 

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Drew Nelson

Tim Pullen

Amy Barlow

Headland Consultancy (Financial PR)+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

· handset devices

· global telecoms infrastructure

· connected devices

· 3D sensing

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 650 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABRBDGDGXDGGG
Date   Source Headline
30th Apr 20247:00 amRNSTotal Voting Rights
10th Apr 20247:01 amRNSIQE plc: AWSC and Lansus customer partnership
10th Apr 20247:00 amRNSIQE plc: FY 2023 Financial Results
3rd Apr 20244:00 pmRNSIQE plc: Notice of Results
2nd Apr 20242:30 pmRNSIQE plc: Holding(s) in Company
2nd Apr 202410:00 amRNSIQE plc: Total Voting Rights
26th Mar 20247:00 amRNSIQE plc: AI for datacomms portfolio expansion
5th Mar 20244:40 pmRNSIQE plc: Holding(s) in Company
4th Mar 20243:15 pmRNSIQE plc: Holding(s) in Company
4th Mar 202412:30 pmRNSIQE plc: Holding(s) in Company
29th Feb 20247:00 amRNSIQE: Options Issue & Director/PDMR Shareholding
6th Feb 20247:00 amRNSIQE plc: Block Admission
5th Feb 20247:00 amRNSIQE plc: Holding(s) in Company
2nd Feb 202412:30 pmRNSIQE plc: Holding(s) in Company
1st Feb 20247:00 amRNSIQE plc: Holding(s) in Company
31st Jan 20244:00 pmRNSIQE plc: Total Voting Rights
24th Jan 20244:00 pmRNSIQE plc - Total Voting Rights and Block Admission
22nd Jan 20247:01 amRNSIQE plc: Holding(s) in Company
22nd Jan 20247:00 amRNSIQE plc: Holding(s) in Company
16th Jan 20247:01 amRNSIQE plc: Chief Financial Officer appointment
16th Jan 20247:00 amRNSIQE plc: Trading Update
9th Jan 20247:00 amRNSIQE plc: Appointment of VP of Government Affairs
8th Jan 20247:00 amRNSIQE plc: Raytheon qualifies IQE North Carolina
5th Jan 202412:05 pmRNSIQE plc: Holding(s) in Company
5th Jan 202412:00 pmRNSIQE plc: Holding(s) in Company
15th Dec 202312:00 pmRNSIQE plc: Holding(s) in Company
12th Dec 20234:00 pmRNSIQE plc: Long Term Incentive Plan (LTIP) Award
11th Dec 20237:00 amRNSIQE and Cardiff University extend partnership
4th Dec 20239:00 amRNSIQE plc: Total Voting Rights
29th Nov 20234:00 pmRNSLong Term Incentive Plan (LTIP) Award
29th Nov 20237:00 amRNSIQE plc: Board Appointments
14th Nov 202312:00 pmRNSIQE plc: Holding(s) in Company
10th Nov 20237:00 amRNSIQE plc: Director/PDMR Shareholding
31st Oct 20234:00 pmRNSIQE plc: Total Voting Rights
2nd Oct 20234:00 pmRNSIQE plc: Total Voting Rights
2nd Oct 202312:00 pmRNSIQE plc: Long Term Incentive Plan (LTIP) Award
2nd Oct 20237:00 amRNSIQE plc: Industry first 6" InP DFB Laser Platform
26th Sep 20239:00 amRNSIQE plc: Holding(s) in Company
20th Sep 20234:00 pmRNSIQE plc: Holding(s) in Company
19th Sep 20238:00 amRNSIQE plc: Holding(s) in Company
19th Sep 20237:00 amRNSIQE plc:VisIC Technologies strategic collaboration
12th Sep 20237:00 amRNSIQE plc: H1 2023 Interim Results
1st Sep 20234:00 pmRNSIQE plc: Total Voting Rights
25th Aug 20237:00 amRNSIQE plc: Notice of Results
11th Aug 20234:00 pmRNSIQE plc: Holding(s) in Company
3rd Aug 20238:30 amRNSIQE plc: CEO joins UK Government Advisory Panel
2nd Aug 20234:45 pmRNSIQE plc: Holding(s) in Company
1st Aug 20237:00 amRNSIQE plc: Total Voting Rights
26th Jul 20237:00 amRNSIQE plc: Trading Update
6th Jul 20235:27 pmRNSReplacement: Result of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.